Treatment of canine hemangiosarcoma: 2000 and beyond

Journal of veterinary internal medicine / American College of Veterinary Internal Medicine

Volumn 14, Issue 5, 2000, Pages 479-485

  Clifford, Craig A ^a   Mackin, Andrew J ^b   Henry, Carolyn J ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; IMMUNOLOGICAL ADJUVANT; TETRACYCLINE DERIVATIVE; THALIDOMIDE;

ANGIOSARCOMA; ANIMAL; ANIMAL DISEASE; DOG; DOG DISEASE; FEMALE; HEART TUMOR; INHALATIONAL DRUG ADMINISTRATION; MALE; PATHOLOGY; REVIEW; SKIN TUMOR; SPLEEN TUMOR;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INHALATION; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOG DISEASES; DOGS; FEMALE; HEART NEOPLASMS; HEMANGIOSARCOMA; MALE; SKIN NEOPLASMS; SPLENIC NEOPLASMS; TETRACYCLINES; THALIDOMIDE;

EID: 0034277005     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2000.tb02262.x     Document Type: Review

References (0)